Combined Cardiac Surgery and Liver Transplant Is a New Option for Highly Selected Patients
Consult QD
FEBRUARY 2, 2024
Coronary artery disease (CAD) is estimated to occur in as many as 30% of patients with end-stage liver disease (ESLD), a rate much higher than the estimated 6% of the general public. However, heart failure before, during and after liver transplantation can be devastating and life-threatening. So, patients with multiple comorbidities may feel like they don’t have any options in terms of treatment.
Let's personalize your content